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Abstract
Chemotherapy and radiotherapy are performed for cancer patients with the hope that dying cancer cells are safely
scavenged by phagocytic cells such as macrophages. In this study, we examined cytokine production by macrophages during
and after the phagocytosis of etoposide-treated P388 cells in vitro and in vivo. Etoposide caused apoptosis as early as 5 h
after treatment, as assessed as to the exposure of phosphatidylserine, increase in membrane permeability and DNA ladder
formation. Phagocytosis by phorbol myristate acetate (PMA)-treated THP-1 cells occurred marginally when P388 cells were
treated with etoposide for 10 h, while it occurred significantly with P388 cells treated for 24 h, as evidenced by flow cytometry
and confocal microscopy. PMA-treated THP-1 cells produced pro-inflammatory cytokines, such as interleukin (IL)-1K, IL-8
and macrophage migration inhibitory factor (MIF), but not anti-inflammatory cytokines among those tested at the mRNA
level during and after the phagocytosis of apoptotic cells. IL-8 and MIF were also produced at the protein level, and the IL-8
production was dependent on cell-to-cell contact when the plasma membranes of apoptotic cells were intact enough not to
leak one of the cytoplasmic enzymes, lactate dehydrogenase. In addition, etoposide-treated P388 cells induced neutrophil
infiltration as well as MIP-2 production upon injection into the peritoneal cavity of either normal mice or mice with sterile
peritonitis. When macrophages ingesting and/or binding apoptotic P388 cells were isolated from the mice with sterile
peritonitis using a cell sorter, they were found to produce MIP-2 upon culture. ß 2001 Elsevier Science B.V. All rights
reserved.
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1. Introduction
Chemotherapy and radiotherapy are ideal for kill-
ing malignant cells in cancer patients, because such
therapies induce apoptosis of these cells [1], and be-
cause the therapy-induced apoptotic cells are be-
lieved to be safely scavenged by phagocytic cells
such as macrophages [2]. Apoptosis is regulated by
a set of proteins including p53, whose mutation ap-
pears to explain much of the failure of such therapies
[3]. Therefore gene therapy to introduce the wild-type
p53 has been considered to overcome the lack of
induction of apoptosis, although the gene status of
p53 is not always highly predictive of the treatment
outcome in cancer patients [4].
Since macrophages produce a variety of cytokines
in response to bacteria, viruses, tumor cells, and im-
mune complexes, macrophages may also produce cy-
tokines during and after the phagocytosis of chemo-
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therapeutic agent-treated cells. Identi¢cation of the
cytokines produced may lead to improvement of
the e⁄cacy of these therapies in cancer treatment.
Chemotherapy and radiotherapy commonly cause
bone marrow toxicity, which results in a dramatic
decrease in the number of circulating neutrophils in
particular, and thus granulocyte colony-stimulating
factor (G-CSF), for instance, reportedly improves
their e⁄cacy by allowing both increases in their
doses and decreases in vulnerability to serious infec-
tion [5]. Although neutrophils are reportedly critical
in cytokine-based gene therapy [6], little attention has
been paid to the role of neutrophils as e¡ector cells
in combination therapies involving chemotherapeutic
agents and G-CSF.
Etoposide is one of the chemotherapeutic agents
which are currently used in clinics, and is well known
to inhibit topoisomerase II, thereby inducing apopto-
sis of a variety of cells [7,8]. P388 cells are one of the
types of cancer cells which have been employed as a
model for assessing the e⁄cacy of chemotherapeutic
agents in vitro and in vivo [9]. In this study, we ¢rst
examined cytokine production by coculturing macro-
phages with etoposide-treated P388 cells and then
examined the in vivo response following intraperito-
neal injection of etoposide-treated P388 cells.
2. Materials and methods
2.1. Preparation of cells
A murine leukemic cell line, P388 cells, was main-
tained in RPMI 1640 medium containing 10% fetal
calf serum (FCS) (Life Technologies, Rockville, MD)
and 1035 M 2-mercaptoethanol (culture medium). A
murine interleukin (IL)-2-dependent T-cell line,
CTLL-2 cells, was maintained in RPMI 1640 me-
dium containing 10% FCS, 5U1035 M 2-mercapto-
ethanol and 100 U/ml recombinant human IL-2
(kindly provided by Takeda Pharmaceutical Co.,
Osaka, Japan). A human monocytic leukemia cell
line, THP-1 cells, was treated with 160 nM phorbol
myristate acetate (PMA) for 72 h at 37‡C for di¡er-
entiation into macrophages, according to the method
described previously [10]. P388 cells were adjusted to
the cell density of 106 cells/ml in the culture medium,
followed by the addition of 1 mg/ml of etoposide
(Wako, Osaka, Japan) to the ¢nal concentration of
1 Wg/ml, and then the cells were incubated for 5, 10
or 24 h at 37‡C. CTLL-2 cells were washed with
prechilled phosphate-bu¡ered saline (PBS) three
times, followed by incubation in IL-2-free medium
for 28 h at 37‡C at the cell density of 5U105 cells/
ml. To induce necrosis, P388 cells were washed with
prechilled PBS three times, followed by adjustment
of the cell density to 106 cells/ml in PBS. The cells
were then subjected to three cycles of freezing at
380‡C for 30 min and thawing at 37‡C for 5 min.
The PMA-treated THP-1 cells were washed with PBS
three times, followed by the addition of etoposide-
treated P388 cells or necrotic P388 cells, at a ratio of
1:2, and incubation for 3 h at 37‡C. As a positive
control for cytokine production, PMA-treated THP-
1 cells were stimulated with 0.1 Wg/ml lipopolysac-
charide (Escherichia coli O55B5; Difco, Detroit,
MI) for 3 h.
2.2. Injection of cells into the peritoneal cavity
CDF1 (6 weeks old, male) mice were purchased
from SLC (Shizuoka, Japan). Mice were injected
with 2 ml of thioglycollate broth intraperitoneally,
and then after 90 h with 2U106 of etoposide-treated
P388 cells suspended in 2 ml of PBS or 2 ml of PBS
intraperitoneally. Normal mice were injected simi-
larly. After 5 h, peritoneal exudate cells (PEC) were
collected with prechilled PBS.
2.3. Flow cytometric analysis [10]
The cell size and expression of phosphatidylserine
(PS) were analyzed by £ow cytometry using a FACS-
can and Lysys software (Becton Dickinson, Moun-
tain View, CA). The expression of PS was estimated
by £uorescein isothiocyanate (FITC)-conjugated an-
nexin V staining. For the phagocytosis assay, etopo-
side-treated P388 cells were stained with propidium
iodide (PI), followed by incubation with PMA-
treated THP-1 cells for 3 h at 37‡C. The cells were
recovered by gentle £ushing with prechilled PBS and
tapping of the bottom of the plate. Cell in¢ltration to
the peritoneal cavity was examined by £ow cytomet-
ry. PEC were incubated with Fc block (PharMingen,
SanDiego, CA), and then with FITC-conjugated rat
anti-mouse Gr-1 (RB6-8C5) antibodies (PharMin-
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gen) or FITC-conjugated rat IgG (PharMingen) for
30 min on ice. The cells were then washed twice with
PBS and analyzed by £ow cytometry.
2.4. Isolation of macrophages ingesting and/or binding
apoptotic P388 cells by a cell sorter
Thioglycollate-treated CDF1 mice were injected
with 2U106 of etoposide-treated P388 cells stained
with PI. After 1 h, PEC were collected with pre-
chilled PBS, washed with PBS once and stained
with FITC-conjugated anti mouse F4/80 antibody
(Cosmo Bio, Tokyo) following incubation with Fc
block and heat-inactivated mouse serum. F4/80-
positive and PI-positive cell population was then
sorted with Epics Altra (Beckman Coulter, Tokyo).
The cells were observed under confocal microscopy
immediately or after a 3-h culture as described be-
low.
2.5. Assaying of DNA fragmentation [11]
Cells were washed with PBS twice, and then lysed
with lysis bu¡er comprising 10 mM Tris^HCl (pH
7.4), 10 mM EDTA and 0.5% Nonidet P-40 for 10
min at 4‡C. After centrifugation at 16 000 rpm for 20
min at 4‡C, the supernatant was incubated with 0.4
mg/ml of RNase A for 1 h at 37‡C, followed by
incubation with 0.4 mg/ml of proteinase K for 1 h
at 37‡C. DNA was precipitated with an equal vol-
ume of isopropanol/0.5 M NaCl at 320‡C overnight.
Samples derived from 1U106 cells were analyzed by
2% agarose gel electrophoresis. It should be noted
here that only fragmented DNA can be recovered
with this method.
2.6. Confocal microscopy [10]
Etoposide-treated P388 cells were stained with PI,
followed by culturing with macrophages for 3 h at
37‡C. The cells were washed, and adherent cells were
recovered as described above. The cells were then
stained with FITC-conjugated mouse monoclonal
antibody (mAb) to human HLA (ABC) class I (Se-
rotec) for 15 min at 4‡C. The cells were examined by
confocal microscopy using an InSIGHT plus-IQ sys-
tem (Meridian Instruments) or Fluoroview system
(Olympus).
2.7. Inhibitors
Phospho-L-serine (PLS), RGDS (Arg-Gly-Asp-
Ser), and RGES (Arg-Gly-Glu-Ser) were purchased
from Sigma (St Louis, MO). PMA-treated THP-1
cells were pretreated with these inhibitors for 30
min at 37‡C. Etoposide-treated P388 cells were then
added, followed by incubation for 3 h at 37‡C, after
which cytokine production was evaluated.
2.8. Reverse transcriptase^polymerase chain reaction
(RT^PCR)
Total RNA was isolated from a coculture, and
RT^PCR was performed as previously described
[10]. For semiquantitation, cDNA was serially di-
luted, followed by RT^PCR with L2-microglobulin
(L2-m) and cytokine primers, and polyacrylamide
gel electrophoresis. After measurement of the inten-
sity of each band, the results were expressed as
percentage of L2-m. The primers (5P primer and 3P
primer), annealing temperatures, concentrations of
MgCl2, and predicted sizes were previously des-
cribed, except for MCP-1 and macrophage migration
inhibitory factor (MIF). MCP-1: CCTGCTGCTA-
TAACTTCACC, TCAAGTCTTCGGAGTTTGGG,
59‡C, 2 mM, 203 bp [12]; MIF: CTGCACAGCAT-
CGGCAAGAT, TTTCTCCCCACCAGAAGGTT,
60‡C, 2 mM, 267 bp [13].
2.9. Measurement of human IL-8, human MIF,
human IL-1K and mouse MIP-2
After coculturing of macrophages with etoposide-
treated P388 cells, the supernatants were harvested.
PEC were recovered from mice injected with etopo-
side-treated P388 cells and centrifuged, followed by
harvesting of the supernatants. Samples were stored
at 380‡C until the assay. The human IL-8 level was
determined by means of a speci¢c enzyme-linked im-
munosorbent assay (ELISA), for which the reagents
were provided by Dr. K. Matsushima (University of
Tokyo School of Medicine, Tokyo, Japan), as previ-
ously described [10]. The detection limit was 10 pg/ml.
Human MIF level was determined by means of a
speci¢c ELISA comprising biotinylated anti-human
MIF antibody and anti-human MIF detection anti-
body (RpD Systems, Minneapolis, MN). The detec-
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tion limit was 10 pg/ml. Human IL-1K level was de-
termined by means of a speci¢c ELISA (Amersham
Pharmacia Biotech, UK). The detection limit was 0.1
pg/ml. The mouse MIP-2 level was determined by a
speci¢c ELISA according to the method previously
described [14]. The detection limit was 20 pg/ml.
2.10. Statistics
The signi¢cance of the data was evaluated by
means of the Welch method or Student’s t-test.
3. Results
3.1. Kinetics of the apoptosis of P388 cells induced by
etoposide
P388 cells were treated with 1 Wg/ml etoposide for
various times, and then the exposure of phosphati-
dylserine (PS), membrane permeability and DNA
fragmentation were evaluated. As shown in Fig. 1
(left panels), annexin V-positive cells increased in a
time-dependent manner, and a small portion of cells
was positive as early as 5 h after treatment. Etopo-
side also increased the membrane permeability in a
time-dependent manner, as shown in Fig. 1 (right
panels), as assessed as to stainability with PI. Anoth-
er indicator of the membrane permeability, trypan
blue dye exclusion, showed a gradual loss of mem-
brane intactness, the cell viability being 98 þ 1% at
5 h, 91 þ 1% at 10 h, and 59 þ 5% at 24 h after treat-
ment. Lactate dehydrogenase, one of the cytosolic
enzymes, was also detected extracellularly at 10 and
24 h, but not at 5 h (0% at 5 h, 9.6% at 10 h, and
42.8% at 24 h), con¢rming the gradual loss of mem-
brane intactness. DNA fragmentation was detected
10 h after treatment, although a small level of
DNA fragmentation was detected at 5 h (Fig. 2).
3.2. Phagocytosis of etoposide-treated P388 cells by
PMA-treated THP-1 cells
The human monocytic leukemia-derived cell line,
Fig. 2. Kinetics of DNA fragmentation of P388 cells induced
by etoposide. P388 cells were treated with 1 Wg/ml etoposide for
various times, and then DNA fragmentation was examined ac-
cording to the method described in Section 2. M denotes molec-
ular mass markers.
Fig. 1. Kinetics of the apoptosis of P388 cells induced by eto-
poside. P388 cells were treated with 1 Wg/ml etoposide for vari-
ous times, and then the exposure of PS (left panels) and in-
crease in membrane permeability (right panels) were examined
according to the methods described in Section 2. The experi-
mental pro¢les are shaded, while the control pro¢le is outlined.
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THP-1, is known to become plastic-adherent and to
acquire increased phagocytic ability on treatment
with PMA [15]. We therefore examined the phagocy-
tosis of etoposide-treated P388 cells by PMA-treated
THP-1 cells by £ow cytometry. PI-stained etoposide-
treated P388 cells were cocultured with PMA-treated
THP-1 cells for 3 h at 37‡C. Then the adherent cells
were recovered and analyzed by £ow cytometry
(Fig. 3). The size of adherent cells increased on co-
culturing with P388 cells, which had been treated
with etoposide for 24 h (Fig. 3G). Furthermore,
when cocultured with etoposide-treated P388 cells
stained with PI, PMA-treated THP-1 cells became
positive, exhibiting red £uorescence, as shown in
Fig. 3F,H. Thus, these results indicated that the lon-
ger P388 cells were treated with etoposide the more
P388 cells were phagocytosed, and that all the PMA-
treated THP-1 cells participated in the phagocytosis.
The phagocytosis of etoposide-treated P388 cells
by PMA-treated THP-1 cells was also con¢rmed by
confocal laser microscopy. Here etoposide-treated
P388 cells were stained with PI, whereas PMA-
treated THP-1 cells were stained with FITC-conju-
gated mouse mAb to human HLA class I. Fig. 4
clearly demonstrates that PI-stained etoposide-
treated P388 cells were engulfed by PMA-treated
THP-1 cells.
3.3. Cytokine production after coculturing of
PMA-treated THP-1 cells with etoposide-treated
P388 cells
We then examined the cytokine production after
coculturing of PMA-treated THP-1 cells with etopo-
side-treated P388 cells by means of semiquantitative
RT^PCR. The cytokines examined were IL-1K,
IL-1L, IL-6, IL-8, tumor necrosis factor-K, MCP-1,
MIF, IL-1 receptor antagonist, IL-10, and trans-
forming growth factor-L. The former seven cytokines
are pro-in£ammatory, whereas the latter three are
anti-in£ammatory. When PMA-treated THP-1 cells
were cocultured with etoposide-treated P388 cells for
3 h, they expressed the mRNAs of three pro-in£am-
matory cytokines, IL-1K, IL-8 and MIF (Fig. 5A,B).
Although other cytokine mRNAs were also exam-
ined, none of them were found to be expressed
Fig. 4. Confocal microscopic analysis of etoposide-treated P388
cells that have been phagocytosed by macrophages. P388 cells
were treated with etoposide for 24 h and then stained with PI,
followed by coculturing with macrophages for 3 h at 37‡C. The
adherent cells were recovered, stained with FITC-conjugated
mouse mAb to human HLA (ABC) class I (Serotec) for 15 min
at 4‡C, and then examined by confocal microscopy.
Fig. 3. Phagocytosis of etoposide-treated P388 cells by PMA-
treated THP-1 cells. PI-stained P388 cells treated with etoposide
for 24 h or PI-stained apoptotic CTLL-2 cells were cocultured
with PMA-treated THP-1 cells for 3 h at 37‡C as described in
Section 2, followed by evaluation of cell size (left panels) and
red £uorescence (right panels) by £ow cytometry. The experi-
mental pro¢les are shaded, while the control pro¢le is outlined.
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(data not shown). Coculturing of PMA-treated THP-
1 cells with P388 cells treated with etoposide for 24 h
produced greater levels of the mRNAs for IL-1K,
IL-8 and MIF than that with P388 cells treated
with etoposide for 10 h. MCP-1 mRNA was pro-
duced only on the coculturing of PMA-treated
THP-1 cells with necrotic P388 cells.
The protein levels of IL-8 in the supernatants of
cocultures of PMA-treated THP-1 cells with etopo-
side-treated P388 cells were assayed by means of a
speci¢c ELISA, as described in Section 2 (Fig. 6A).
The results of IL-8 protein production were essen-
tially the same as those of IL-8 mRNA production
in Fig. 5. The protein levels of MIF and IL-1K in
the supernatants were also assayed by means of
speci¢c ELISAs (Fig. 7 and data not shown).
PMA-treated THP-1 cells by themselves produced
the similar amount of MIF, 4.4 þ 0.8 ng/ml, as those
cocultured with normal P388 cells (Fig. 7), and
Fig. 6. IL-8 production upon coculturing of PMA-treated THP-
1 cells with etoposide-treated or necrotic P388 cells. (A) The
levels of IL-8 in the supernatants of cocultures of PMA-treated
THP-1 cells (macrophages) with etoposide-treated or necrotic
P388 cells were determined by means of a speci¢c ELISA, as
described in Section 2. (B) Some cocultures were carried out in
a double-chamber culture system (Millipore) to separate macro-
phages from etoposide-treated or necrotic P388 cells. The ex-
periments were performed in triplicate. IL-8 production with
the double-chamber culture system is contact-independent, and
the relative contact independency was calculated as the ratios
between the IL-8 production with and without the double-
chamber culture system. The results are expressed as mean-
s þ standard error.
Fig. 5. Cytokine production upon coculturing of PMA-treated
THP-1 cells with etoposide-treated or necrotic P388 cells. (A)
Polyacrylamide gel electrophoretic pattern of each RT^PCR
product. PMA-treated THP-1 cells (macrophages) were cocul-
tured with P388 cells treated with etoposide for 10 or 24 h, ne-
crotic P388 cells, or apoptotic CTLL-2 cells. Total RNA was
extracted and subjected to RT^PCR, as described in Section 2.
The picture is representative of two independent experiments.
(B) The relative amount of each mRNA was determined as de-
scribed in Section 2, and expressed as a percentage of the
amount of L2-m.
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MIF protein production was slightly but not signi¢-
cantly increased upon coculturing with apoptotic
P388 cells (Fig. 7). IL-1K was not detected in any
supernatants. Thus the results of MIF and IL-1K
protein production were quite di¡erent from those
of MIF and IL-1K mRNA production in Fig. 5 (see
Section 4).
3.4. Inhibition of cytokine production by either
PLS, RGDS or RGES
We then examined whether or not cytokine pro-
duction was inhibited by either PLS, RGDS or
RGES. PLS and RGDS were reported to block the
interaction of macrophages with apoptotic cells via
the PS receptor and the vitronectin receptor, respec-
tively [16,17]. PLS tended to block IL-8 mRNA pro-
duction more signi¢cantly than RGDS or RGES
(Fig. 5B), whereas IL-8 protein production was sup-
pressed by either PLS or RGDS (Fig. 6A). MIF
mRNA production was suppressed by either RGDS
or RGES more signi¢cantly than by PLS (Fig. 5B),
whereas MIF protein production was only slightly
suppressed by either PLS, RGDS or RGES (Fig.
7). IL-1K mRNA production was enhanced by PLS
and suppressed by either RGDS or RGES (Fig. 5B).
3.5. Contact-dependent and -independent production
of IL-8
In order to determine whether or not cell-to-cell
Fig. 8. In vivo response following intraperitoneal injection of etoposide-treated P388 cells. CDF1 mice with sterile peritonitis (A,
n = 7) or normal CDF1 mice (B, n = 6) were injected with PBS, normal P388 cells, or P388 cells treated with etoposide for 24 h, fol-
lowed by collection of PEC 5 h later. The total number of PEC, total number of neutrophils, and amount of MIP-2 were determined
as described in Section 2. The results are expressed as means þ standard error. nd, not detected. Statistical signi¢cance was evaluated
either by Welch method (A: MIP-2 for normal cells vs. MIP-2 for apoptotic cells ; B: neutrophil number for PBS vs. neutrophil num-
ber for normal cells ; B: total cell number for normal cells vs. total cell number for apoptotic cells) or by Student’s t-test (others).
NS, not signi¢cant.
Fig. 7. MIF production upon coculturing of PMA-treated
THP-1 cells with etoposide-treated P388 cells. The levels of
MIF in the supernatants of cocultures of PMA-treated THP-1
cells (macrophages) with etoposide-treated P388 cells were de-
termined by means of a speci¢c ELISA, as described in Section
2.
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contact is required for subsequent IL-8 production,
we employed a double-chamber culture system for
the coculture of etoposide-treated P388 cells with
PMA-treated THP-1 cells. IL-8 production in the
double-chamber culture system is cell-to-cell con-
tact-independent. As shown in Fig. 6B, IL-8 produc-
tion by 24 h-treated P388 cells was much more con-
tact-independent than that by 5 h- and 10 h-treated
P388 cells, and the contact-independency appears to
be reversely related to the intactness of the mem-
branes of apoptotic cells. When necrotic P388 cells
were used, IL-8 production was the most contact-
independent, as would be expected. We then sepa-
rated necrotic P388 cells into a pellet and a super-
natant, and examined the e¡ect of the double-cham-
ber culture system. The inductive activity in the
supernatant as to IL-8 production was much more
contact-independent than that in the pellet.
3.6. In vivo response following intraperitoneal
injection of etoposide-treated P388 cells
We then examined the in vivo response following
intraperitoneal injection of etoposide-treated P388
cells into mice with sterile peritonitis or normal
mice. Based on the preliminary results, PEC cells
were collected 5 h after injection of etoposide-treated
or normal P388 cells. As shown in Fig. 8A,B, the
numbers of neutrophils were signi¢cantly greater
than those for normal P388 cells. The levels of
MIP-2, a murine homolog of IL-8, in peritoneal exu-
dates paralleled the numbers of neutrophils, although
the level of MIP-2 in normal mice was lower than
that in thioglycollate-treated mice.
In order to determine whether or not macrophages
ingesting apoptotic cells produce MIP-2, we then pu-
ri¢ed macrophages ingesting and/or binding PI-
stained apoptotic P388 cells 1 h after peritoneal in-
jection by a cell sorter, as described in Section 2.
Fluorescent microscopy revealed that essentially all
macrophages were associated with apoptotic cells,
and approximately 17% of macrophages ingested ap-
optotic cells as evidenced by confocal microscopy
(Fig. 9A). There were many macrophages not associ-
ated with apoptotic cells in Fig. 9A, probably because
confocal microscopy gives a dissected image of a cell
at a given point along the z-axis. After a 3-h culture,
approximately 43% of macrophages ingested apopto-
tic cells (Fig. 9B). The supernatants taken from such
macrophages ingesting and/or binding apoptotic cells
were found to contain 40.5 þ 2.8 ng/ml of MIP-2, the
level of which was very much close to that obtained
by coculturing thioglycollate-induced PEC with apo-
ptotic P388 cells for 3 h, 43.5 þ 0.6 ng/ml.
4. Discussion
This study demonstrated the production of pro-
in£ammatory cytokines, notably IL-8, by PMA-
Fig. 9. Confocal microscopic analysis of macrophages ingesting and/or binding apoptotic P388 cells. P388 cells were treated with eto-
poside for 24 h and then stained with PI, followed by peritoneal injection. One hour later, the peritoneal exudate cells were recovered,
stained with FITC-conjugated anti F4/80 antibody, and then PI-positive and F4/80-positive cells were sorted, followed by observation
under confocal microscopy immediately (A) or after a 3-h culture (B).
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treated THP-1 cells during and after the phagocyto-
sis of etoposide-treated P388 cells. Moreover, intra-
peritoneal injection of etoposide-treated P388 cells
into mice with sterile peritonitis and normal mice
induced neutrophil in¢ltration and MIP-2 produc-
tion. When macrophages ingesting and/or binding
apoptotic P388 cells were puri¢ed by a cell sorter,
they were found to produce the similar amount of
MIP-2 upon further culture as those cocultured with
apoptotic P388 cells in vitro, further supporting that
these two ¢ndings in vitro and in vivo are intimately
correlated.
During treatment of P388 cells with etoposide,
membrane intactness was gradually lost, and the
IL-8 production became partly independent of cell-
to-cell contact. Moreover, necrotic P388 cells also
induced the production of IL-8, which was mediated
mainly by a cell-to-cell contact-independent mecha-
nism. Therefore, the production of large amounts of
pro-in£ammatory cytokines observed in this study is
likely to be induced by either late apoptotic or sec-
ondary necrotic cells, which occur under pathological
conditions such as ischemia reperfusion injury,
although P388 cells treated with etoposide for 5 h,
i.e., early apoptotic cells, induced the production of a
smaller but signi¢cant level of IL-8. This observation
may be related to neutrophil in¢ltration following
apoptosis [18,19].
This study focused on cytokine production by
macrophages during and after the phagocytosis of
etoposide-treated P388 cells in vitro and in vivo. Eto-
poside and X-irradiation are known to cause bone
marrow toxicity, thereby reducing the number of
neutrophils. Since we recently found that X-irradia-
tion induced apoptosis in the thymus as well as tran-
sient in¢ltration of neutrophils [19], it is possible that
etoposide induces similar responses in mice bearing
P388 cells. In support of this possibility, neutrophil
in¢ltration was induced not only in mice with sterile
peritonitis but also in normal mice by intraperitoneal
injection of etoposide-treated P388 cells. If a similar
response does occur in tumor bearing mice in re-
sponse to chemotherapeutic agents, what role might
in¢ltrating neutrophils play? In bronchioloalveolar
carcinomas, tumor-derived IL-8 is reportedly associ-
ated with a high risk of death [20]. In contrast, neu-
trophils are reportedly critical in cytokine-based gene
therapy [6]. Thus future study should reveal whether
or not the activation of in¢ltrating neutrophils may
be bene¢cial for cancer treatment.
Among the seven pro-in£ammatory cytokines ex-
amined, IL-1K, IL-8 and MIF mRNAs were detected
in cocultures of etoposide-treated P388 cells with
macrophages. Although we also examined produc-
tion of IL-1K and MIF proteins, IL-1K was not de-
tected in any culture supernatants and MIF produc-
tion was only slightly enhanced by coculturing with
apoptotic cells. The failure of protein production
may be explained by that these two cytokines are
known to have no signal peptide for secretion. So
the biological signi¢cance of the production of IL-
1K and MIF mRNAs is not known at present. How-
ever, MIF is reported to be capable of functionally
inactivating p53 [21], and therefore the production of
MIF mRNA by macrophages in response to either
apoptotic cells or necrotic cells, which may occur in a
chronic in£ammatory disease, may strengthen the
link between in£ammation and tumorigenesis, as
suggested [21].
Interestingly, MCP-1 mRNA was detected in a
coculture of necrotic P388 cells, but not etoposide-
treated P388 cells, with macrophages, supporting the
notion that necrotic and apoptotic cells are not the
same in terms of the biological response induced by
them. If the number and/or capacity of macrophages
are not su⁄cient to remove apoptotic cells, apoptosis
may advance further to give rise to secondary ne-
crotic cells. Consequently it is reasonable to assume
that necrotic cells induce the in¢ltration of macro-
phages through MCP-1, because MCP-1 is a chemo-
tactic factor for monocyte and macrophages [22].
Presumably because P388 cells treated with etoposide
for 24 h were not completely necrotic, these cells
might not have induced MCP-1 production.
In conclusion, this study demonstrated a novel re-
sponse during and after the phagocytosis of etopo-
side-induced apoptotic P388 cells in vitro and in
vivo, and suggested that neutrophils may in¢ltrate
into the sites where chemotherapeutic agents induce
massive apoptosis.
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